top of page
< Back

Leuprorelin/Leuprolide


Mechanism of action:

Leuprorelin is a gonadotropin-releasing hormone analog and is a synthetic peptide. Initially, leuprorelin continuously stimulates gonadotropin-releasing hormone receptors in the anterior pituitary, causing a temporary rise in luteinizing hormone (LH) and follicle-stimulating hormone (FSH) secretion, which in turn transiently increases testosterone in males or estrogen in females. With continued administration, prolonged receptor stimulation leads to desensitization and downregulation of gonadotropin-releasing hormone receptors, causing marked suppression of LH and FSH secretion from the pituitary. Ultimately, this can reduce testosterone in males to castration levels (chemical castration) and markedly lower estrogen levels in females.

Reference(s):

1. Hoda MR et al. (2017). Androgen deprivation therapy with Leuprolide acetate for treatment of advanced prostate cancer. Expert Opin Pharmacother. 


2. Ali M et al. (2018). Successes and failures of uterine leiomyoma drug discovery. Expert Opin Drug Discov.

bottom of page